Adaptive Biotechnologies (ADPT)
(Delayed Data from NSDQ)
$4.86 USD
+0.46 (10.45%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.30 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | 18.75% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.23 |
Next Year | -1.00 |
EPS (TTM) | -1.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 40.69M | 46.34M | 172.32M | 210.94M |
# of Estimates | 5 | 4 | 5 | 5 |
High Estimate | 41.22M | 48.13M | 173.61M | 220.80M |
Low Estimate | 40.32M | 42.50M | 168.00M | 202.40M |
Year ago Sales | 37.92M | 45.78M | 170.28M | 172.32M |
Year over Year Growth Est. | 7.30% | 1.22% | 1.20% | 22.41% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.30 | -0.30 | -1.23 | -1.00 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.28 | -0.25 | -1.17 | -1.02 |
High Estimate | -0.27 | -0.25 | -1.17 | -0.82 |
Low Estimate | -0.35 | -0.33 | -1.30 | -1.26 |
Year ago EPS | -0.35 | -0.30 | -1.38 | -1.23 |
Year over Year Growth Est. | 14.29% | 0.00% | 10.87% | 18.70% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 3 | 3 | 2 |
Up Last 60 Days | 3 | 3 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.30 | -0.30 | -1.23 | -1.00 |
7 Days Ago | -0.30 | -0.30 | -1.23 | -1.00 |
30 Days Ago | -0.32 | -0.32 | -1.29 | -1.02 |
60 Days Ago | -0.32 | -0.32 | -1.29 | -1.02 |
90 Days Ago | -0.32 | -0.32 | -1.29 | -1.02 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.30 | -0.29 | -1.21 | -0.91 |
Zacks Consensus Estimate | -0.30 | -0.30 | -1.23 | -1.00 |
Earnings ESP | 0.00% | 1.70% | 1.89% | 8.67% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.33 | -0.30 | -0.35 | NA |
Estimate | -0.32 | -0.35 | -0.32 | -0.32 | NA |
Difference | 0.06 | 0.02 | 0.02 | -0.03 | 0.02 |
Surprise | 18.75% | 5.71% | 6.25% | -9.38% | 5.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more